Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PLOD2 in cancer research.

Hongzhi Du1, Mao Pang2, Xiaoying Hou1

  • 1Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, Jiangsu, China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 18, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A structurally defined acidic Angelica sinensis polysaccharide synergizes with αGalCer as adjuvants to enhance humoral and cellular immunity.

International journal of biological macromolecules·2026
Same author

Imaging characteristics of gastrointestinal foreign bodies in children and analysis of risk factors associated with the severity of complications.

Frontiers in pediatrics·2026
Same author

Anti-pathogenic effects of Artemisia argyi and its applications: the past, present, and future.

Chinese journal of natural medicines·2026
Same author

Velamentous cord insertion in singleton pregnancies: ultrasound diagnostic accuracy, risk factor analysis, and perinatal outcomes.

Frontiers in medicine·2026
Same author

Steroids and flavonoids in TRQ ameliorates chronic obstructive pulmonary disease involving Pink1/Parkin-mediated mitophagy.

Scientific reports·2026
Same author

<i>iMeta</i> Conference 2025: Creating high-impact international journals.

iMeta·2025

Lysyl hydroxylases 2 (PLOD2) enzyme drives cancer cell invasion by stabilizing collagen. Inhibiting PLOD2 shows anti-metastasis effects, suggesting its potential as a therapeutic target for cancer treatment.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cancer Research
  • Extracellular Matrix Biology

Background:

  • Collagen, the most abundant protein, forms the extracellular matrix (ECM) scaffold and influences cancer cell migration.
  • Stabilized collagen accumulation, mediated by covalent cross-links, is crucial for ECM integrity and cancer progression.
  • Lysyl hydroxylases 2 (PLOD2) is the key enzyme in forming stabilized collagen cross-links and is overexpressed in various cancers.

Purpose of the Study:

  • To review the function, regulatory mechanisms, and inhibitors of PLOD2 in the context of cancer research.
  • To highlight PLOD2's role in cancer cell migration, invasion, and its association with poor prognosis.
  • To explore the potential of PLOD2 as a prognostic biomarker and therapeutic target in oncology.

Main Methods:

Keywords:
Cancer researchLysyl hydroxylase 2MetastasisPLOD2

Related Experiment Videos

  • Literature review of existing studies on PLOD2 in cancer.
  • Analysis of PLOD2's regulatory pathways, including HIF-1α, TGF-β, and microRNA-26a/b.
  • Examination of pharmacologic inhibitors targeting PLOD2 and their anti-metastasis effects.

Main Results:

  • PLOD2 overexpression correlates with poor prognosis in multiple cancer types.
  • Known regulatory mechanisms of PLOD2 include HIF-1α, TGF-β, and microRNA-26a/b.
  • Pharmacologic inhibition of PLOD2 demonstrates significant anti-metastasis effects in preclinical studies.

Conclusions:

  • PLOD2 plays a critical role in cancer progression by promoting collagen stabilization and facilitating cell invasion.
  • PLOD2 represents a credible target for developing novel therapeutic strategies against cancer metastasis.
  • Further clinical evaluation of PLOD2 as a prognostic signature in pathological examinations is warranted.